Abstract
Background: Despite ample evidence demonstrating that anterior cruciate ligament (ACL) and meniscus tears are associated with posttraumatic osteoarthritis (PTOA) development, the contributing factors remain unknown. Synovial inflammation has recently been recognized as a pivotal factor in the pathogenesis of OA. However, there is a lack of data on synovial profiles after ACL or meniscus injuries, which may contribute to PTOA.
Methods: Twelve patients with ACL tears and/or meniscus injuries were recruited. During surgery, synovial tissues were obtained from the injured knees. The inflammation status of the synovium was characterized according to macroscopic criteria and histological synovitis grades. Then the synovial tissues were classified as control group or inflamed group. High-throughput RNA sequencing of the synovial samples (3 vs. 3) was conducted to identify differentially expressed (DE) RNAs. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and protein–protein interaction (PPI) analyses were performed to investigate DE mRNAs. Next, competing endogenous RNA (ceRNA) networks were constructed based on bioinformatics analyses. Associations of the identified DE genes (DEGs) with infiltrating immune cells were explored using Pearson correlation analysis.
Results: The results showed that 2793 mRNAs, 3392 lncRNAs and 211 miRNAs were significantly DE between two groups. The top 3 significantly upregulated GO terms and KEGG pathways were immune response, adaptive immune response and immune system process, systemic lupus erythematosus, haematopoietic cell lineage and cytokine–cytokine receptor interaction, respectively. In PPI networks, the top 10 hub genes were IL6, CCR7, C3, CCR5, CXCR3, CXCL8, IL2, CCR3, CCR2 and CXCL1. Seven mRNAs (EPHA5, GSN, ORC1, TLN2, SOX6, NKD2 and ADAMTS19), 4 lncRNAs (MIR4435-2HG, TNXA, CEROX1 and TMEM92-AS1) and 3 miRNAs (miR-486-5p, miR-199a-3p and miR-21-3p) were validated by quantitative real-time polymerase chain reaction and sub-networks were constructed. In correlation analysis, MMP9 correlated positively with M0 macrophages and plasma cells, NKD2 positively with CD8 T cells, and CCR7 and IL2RB positively with naive B cells.
Conclusion: Our study provides foundational synovial inflammation profiles following knee trauma. The ceRNA and PPI networks provide new insight into the biological processes and underlying mechanisms of PTOA. The differential infiltration profiles of immune cells in synovium may contribute to PTOA development. This study also highlights immune-related DEGs as potential PTOA treatment biomarkers.
Introduction
Osteoarthritis (OA) is the most prevalent form of joint diseases and a major health burden. It is predicted to be the leading cause of disability in the general population by 2030 (). Traumatic meniscal and anterior cruciate ligament (ACL) tears are major causes of this degenerative disease. Astoundingly, approximately 50% of patients eventually develop posttraumatic OA (PTOA) within 10–20 years after joint injury (; ).
However, the mechanism that contributes to the development of PTOA is still unknown. Several studies have detected alterations in knee kinematics and kinetics following ACL tears and meniscus injuries (; ; ), which may contribute to both initiation and progression of OA development. Recently, a renewed focus has been placed on the inflammatory milieu after acute traumatic injury. After joint trauma, increased levels of proinflammatory cytokines, catabolic enzymes, and biomarkers of cartilage breakdown and bone turnover have been detected in synovial fluid, blood, and urine (; ; ; ), which may also play a role in PTOA development. Moreover, a subset of patients after ACL injury who demonstrate significantly greater concentrations of biomarkers show more severe PTOA progression (; ). Notably, patients show variability in responses to anti-inflammatory treatment after ACL injury (), underscoring the need to determine whether different ACL patient phenotypes exist and to explore potential therapeutic targets to lessen chondral degeneration following ACL injury. Recently, proteomic analyses have been performed on synovial fluid collected from patients after acute ACL injury (). In addition, the immune cell profiles of the joint synovial fluid from individuals with ACL or meniscus injuries have been evaluated (). However, the synovial membrane profiles that contribute to or mediate OA progressive cartilage degradation and joint dysfunction have not been studied in patients with ACL and meniscus injuries (; ; ).
Only a few studies have evaluated synovial biopsy characterizations that are altered following joint injury in animal models. Specifically, recent animal model experiments have shown that the synovium may be involved in the progression of PTOA after anterior cruciate ligament rupture or medial meniscus transection (; ; ). In addition, several studies have evaluated synovial profiles in patients with OA (; ; ), showing that noncoding RNAs may play key roles in OA synovitis and may have prospective importance in OA diagnosis and therapy. Furthermore, different gene expression patterns between inflamed and normal areas of the synovium could reveal key pathways involved in OA pathogenesis and provide new potential targets of treatment (). Future studies investigating molecular mechanisms and biologic pathways in synovial membrane may provide an enhanced understanding of the pathophysiology and development of PTOA following joint injury. However, to the best of our knowledge, there is a lack of data on synovial profiles in patients after ACL or meniscus injuries. In addition, studies have demonstrated that noncoding RNA expression patterns are potentially disease specific (; ), supporting the need for further studies focused on profiling noncoding RNAs in the contexts of ACL/meniscus injuries.
Therefore, in this study, high-throughput RNA sequencing (RNA-seq) was conducted to systematically explore different expression profiles of microRNAs (miRNAs), mRNAs and long noncoding RNAs (lncRNAs) between inflamed and normal synovial tissues from patients undergoing ACL and/or meniscus injuries. Moreover, lncRNA–miRNA–mRNA competing endogenous RNA (ceRNA) and protein–protein interaction (PPI) networks were established. Therefore, the purpose of our study was to provide greater insights into molecular mechanisms and biologic pathways that could regulate PTOA progression. In addition, this study aimed to identify new potential targets for the prevention and earlier treatment of PTOA following ACL/meniscus injuries.
Materials and methods
Patients and specimens
Synovial tissue samples from 12 patients with knee trauma were obtained at the time of ACL reconstruction and/or meniscus repair or meniscectomy at the Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. This study was approved by the Ethics Committee at Tongji Medical College (IORG No. IORG0003571), and all subjects provided informed consent.
Patients between 18 and 45 years of age who had a traumatic knee injury and were scheduled for arthroscopic knee procedures were recruited from the Department of Orthopaedics, Union Hospital. The inclusion criteria existence of an isolated ACL injury as determined via clinical examination (positive Lachman test) and validated using magnetic resonance imaging examination and/or a meniscal tear identified on preoperative MRI corresponding to the clinical presentation. The exclusion criteria for the current study included previous traumatic injury to the affected knee, history of diagnosed arthritis, and systemic inflammatory or autoimmune disease.
All the synovium were collected from suprapatellar bursa in all patients and by the same surgeon using biopsy forceps. The inflammation status of the synovial membrane was characterized by the surgeon according to macroscopic criteria (). The synovial membrane was classified into 3 grades, normal, reactive, and inflamed, according to the criteria established by Ayral on the basis of synovial vascularization, villus formation, and hypertrophy of the tissue. The synovial samples were divided into two groups for this study: the normal (control) group and the inflamed group. Twelve individuals (Table 1) met the inclusion criteria. Normal or inflamed synovial biopsy samples were immediately submerged in RNAlater™ Stabilization Solution (Thermo Fisher Scientific, Vilnius, Lithuania). Each sample was stored at 4°C overnight followed by −80°C until RNA extraction.
TABLE 1
| Subject | Sex | Age (years) | BMI (kg/m2) | Time from injury to surgery (days) | Injury type (ACL/meniscal tear) | Status of synovium (inflamed/normal) | Articular cartilage (normal/degenerative/defects) |
|---|---|---|---|---|---|---|---|
| I1 | M | 30 | 25.71 | 14 | ACL and medial meniscal tear | Inflamed | Normal |
| I2 | F | 31 | 28.28 | 14 | ACL tear | Inflamed | Normal |
| I3 | F | 43 | 19.92 | 21 | ACL and medial meniscal tear | Inflamed | Normal |
| I4 | M | 21 | 22.49 | 30 | ACL tear | Inflamed | Normal |
| I5 | M | 30 | 28.4 | 21 | lateral meniscal tear | Inflamed | Normal |
| I6 | F | 44 | 25.39 | 20 | medial meniscal tear | Inflamed | Normal |
| C1 | M | 41 | 27.68 | 14 | ACL and medial meniscal tear | Normal | Normal |
| C2 | M | 23 | 29.24 | 30 | ACL and meniscal tear | Normal | Normal |
| C3 | M | 31 | 31.52 | 27 | ACL, medial and lateral meniscal tear | Normal | Normal |
| C4 | M | 31 | 24.22 | 60 | ACL tear | Normal | Normal |
| C5 | M | 27 | 19.38 | 60 | ACL and medial meniscal tear | Normal | Normal |
| C6 | F | 22 | 20.51 | 24 | lateral meniscal tear | Normal | Normal |
Characteristics and clinical findings of patient groups.
I1-I6 indicated subjects in the inflamed group and C1–C6 represented subjects in the control group.
Hematoxylin-eosin staining
At the same time, the histological features of the collected synovium samples were verified by hematoxylin-eosin (H&E) staining. All the synovial biopsy samples were fixed, dehydrated in xylene, and embedded in paraffin according to standard procedures. Five-micrometer sections were cut and deparaffinized using a standard protocol. These sections were stained with hematoxylin and eosin (H&E) to confirm the inflammatory status of the synovial samples.
RNA extraction and RNA-seq analysis
Total RNA was extracted from the synovial tissues using TRIzol (Invitrogen, Carlsbad, CA, United States) according to the manufacturer’s protocol. The RNA integrity and concentration were assessed using a Nano Drop and an Agilent 2100 bioanalyzer (Thermo Fisher Scientific, MA, United States). Appropriate quality of RNAs were stored at −80°C for mRNA, lncRNA and miRNA sequencing and subsequent experiments.
After the total RNA from each sample was qualified, RNA-seq was performed to identify the differentially expressed (DE) mRNAs, lncRNAs and miRNAs between both groups. Three inflamed subjects and three control subjects were chosen randomly for microarray analysis. Standard cDNA libraries were constructed and sequenced using the DNBSEQ platform (BGI-Shenzhen, China). Furthermore, differential expression analysis was performed using DEGseq (). The significantly dysregulated RNAs had to meet the following criteria: fold changes ≥ 1.5 or ≤ −1.5, p and q values < 0.05.
Gene ontology and kyoto encyclopedia of genes and genomes enrichment analyses
The differentially expressed mRNAs were analyzed with the Gene Ontology (GO) database and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. The GO categories (http://geneontology.org) were used to define the molecular mechanisms and biological functions of the candidate genes. The biological functions of these genes were further annotated with the KEGG database (http://www.genome.jp/kegg). The hypergeometric distribution test was used to identify significantly enriched gene sets. A p value < 0.05 was considered to indicate statistical significance.
Real-time polymerase chain reaction
The remaining RNAs of synovial samples in each group (n = 3 per group) were used to validate the RNA-seq results by using real-time polymerase chain reaction (RT–PCR). miRNAs and other RNAs were reverse-transcribed into cDNA using iTaq™ M-MLV reverse transcriptase (#M170A, Promega) and an iScript cDNA Synthesis Kit (#1708890, Bio–Rad) according to the respective user manuals. RT–PCR was performed on a CFX Connect platform (Bio–Rad, United States) using iTaq™ Universal SYBR Green Supermix (#1725124, Bio–Rad). The primer sequences are presented in Supplementary Tables S1–S3. The relative expression levels of targeted genes were calculated using the 2−ΔΔCt method, and the data were normalized to gapdh (endogenous internal control for mRNA and lncRNA) or u6 (endogenous internal control for miRNA).
Construction of the competing endogenous RNA and protein–protein interaction network
The significantly DE mRNAs and lncRNAs between both groups were used for ceRNA network construction. We used the targeting relationships of mRNAs/lncRNAs regulated by miRNAs to establish a lncRNA–miRNA–mRNA interaction network. The RNAs that could be predicted by at least two of the databases [RNAhybrid (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid), miRanda (http://www.microrna.org/microrna/home.do) and TargetScan (http://www.targetscan.org)] were considered miRNA targets. The sequences of mRNAs and lncRNAs were screened to obtain the potential miRNA response elements. Protein–protein interaction (PPI) analysis of the DE mRNAs was performed based on the STRING database (https://string-db.org). These networks were illustrated using Cytoscape 3.7.1. The degree centrality of the involved genes was calculated by Cytoscan.
Construction of the competing endogenous RNA and protein–protein interaction network
The significantly DE mRNAs and lncRNAs between both groups were used for ceRNA network construction. We used the targeting relationships of mRNAs/lncRNAs regulated by miRNAs to establish a lncRNA–miRNA–mRNA interaction network. The RNAs that could be predicted by at least two of the databases [RNAhybrid (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid), miRanda (http://www.microrna.org/microrna/home.do) and TargetScan (http://www.targetscan.org)] were considered miRNA targets. The sequences of mRNAs and lncRNAs were screened to obtain the potential miRNA response elements. Protein–protein interaction (PPI) analysis of the DE mRNAs was performed based on the STRING database (https://string-db.org). These networks were illustrated using Cytoscape 3.7.1. The degree centrality of the involved genes was calculated by Cytoscan.
Correlation analysis between DEGs and immune cells
The association between the identified DEGs and levels of infiltrating immune cells was explored using Pearson correlation analysis in R software. The resulting associations were visualized using the chart technique with the “ggplot2” package. The complete workflow is shown in Figure 1.
FIGURE 1
Statistical analysis
Statistical analysis was calculated with GraphPad Prism v 8.3.0 software. All data were expressed as the mean ± SEM. Unpaired Student’s t test was performed for comparisons between two groups. Pearson correlation analysis was used to assess the constructed ceRNA network. Statistical significance was set at p or q < 0.05.
Results
Histological features of synovial biopsy samples
Twelve samples from subjects with ACL and/or meniscus injuries were collected (Table 1). During each arthroscopic knee procedure, we collected synovial tissue at the time of surgery for laboratory analysis. The gross appearances of synovial membranes assessed by the surgeon during arthroscopy were confirmed by the histological characteristics. The histological features were highly consistent with the macroscopic views as shown in Figure 2.
FIGURE 2
Differential expression analyses
To identify functional mRNAs, lncRNAs, and miRNAs involved in the inflammatory mechanisms of the synovial membrane, total RNA of synovial tissue samples randomly selected from the inflamed groups and control groups (n = 3) was collected for RNA-seq. All the DE miRNAs, mRNAs and lncRNAs are presented in the hierarchical clustering heatmaps in Figure 3.
FIGURE 3
In total, 211 differentially expressed miRNAs (177 upregulated and 34 downregulated), 2793 differentially expressed mRNAs (1737 upregulated and 1056 downregulated) and 3392 differentially expressed lncRNAs (1623 upregulated and 1769 downregulated) were detected in the inflamed group compared with the control group (Figures 3A–C; Supplementary Data S1–S3).
Functional enrichment analysis of differentially expressed mRNAs
GO and KEGG analyses were performed to investigate the biological effects of the dysregulated mRNAs. First, GO analyses were performed to analyze the up- and downregulated differentially expressed targeted genes. The results revealed that 5055 upregulated and 3571 downregulated GO terms were enriched in the biological process (BP) category. Moreover, 136 GO terms were significantly upregulated, and 15 GO terms were significantly downregulated (Supplementary Data S4, S5). The top upregulated and downregulated enriched terms are listed in Figures 4A,B. Several significant GO terms, such as immune response, immune system process, inflammatory response and chemotaxis, were potentially associated with inflammatory and immune processes following ACL/meniscus injuries (Figure 4A).
FIGURE 4
Pathway enrichment analyses were used to explore key signaling pathways of PTOA. The results showed 41 upregulated and 1 downregulated markedly enriched pathways, as shown in Supplementary Data S6, S7. The top upregulated and downregulated enriched pathways are listed in Figures 4C,D. Among the top upregulated signaling pathways were immune response and inflammatory pathways, such as the rheumatoid arthritis (RA), Th17-cell differentiation, hematopoietic cell lineage and cytokine–cytokine receptor interaction pathways. In comparison, two immune gene databases (InnateDB and Immport) were selected to overlap the DEGs with immune genes. A Venn diagram was constructed, as shown in Figure 5. Eight-three overlapping genes are listed in Supplementary Data S8.
FIGURE 5
Protein–protein interaction network construction
PPI networks were constructed to identify critical genes among the differentially expressed mRNAs. When the inflamed group was compared with the control group, the established network comprised 164 nodes and 923 edges (Figure 6). The topological characteristics of nodes in the PPI network are displayed in Supplementary Data S9. In this network, the top 15 genes with the highest core degrees were IL6, CCR7, C3, CCR5, CXCR3, CXCL8, IL2, CCR3, CCR2, CXCL1, CXCL10, CCL5, AGT, CCR8 and CXCL2.
FIGURE 6
Validation of differentially expressed microRNAs
RT–PCR analysis was performed on RNA extracted from synovial tissues to confirm the expression level changes gained from the RNA-seq analysis. We randomly selected 11 miRNAs with high fold change to validate the reliability of the RNA-seq data. PCR analysis verified that miR-21-3p, miR-486-5p, miR-142-5p and miR-199a-3p were upregulated/downregulated in the inflamed group compared with the control group. These results were consistent with the RNA-seq data (Figure 7). However, PCR analysis showed that miR-103a-3p was upregulated in the inflamed group, which conflicted with the RNA-seq data. The expressions of the remaining six miRNAs were not significantly different between groups according to PCR analysis.
FIGURE 7
Construction of the lncRNA–miRNA–mRNA network
A ceRNA regulatory network was established based on the differentially expressed RNAs. miRNAs validated by RT–PCR analysis, which also showed expression patterns consistent with the RNA-seq results, were selected as the cores of the ceRNA network. The lncRNA–miRNA–mRNA ceRNA network comprised four miRNAs, 211 mRNAs, and 120 lncRNAs (Figure 8). The topological characteristics of nodes in the ceRNA network are displayed in Supplementary Data S10.
FIGURE 8
Real-time polymerase chain reaction validation of differentially expressed mRNAs and long noncoding RNAs
Further RT–PCR analysis of 14 mRNAs and 8 lncRNAs included in the ceRNA networks was performed to confirm the RNA-seq results. The RT–PCR results showed that seven mRNAs were significantly dysregulated (Figure 9A). These results were found to be consistent with the RNA-seq data. However, PCR analysis showed that one mRNA (NOS1) was downregulated in the inflamed group, which conflicted with the RNA-seq data. The expression of the remaining six mRNAs was not significantly different between the groups according to PCR analysis.
FIGURE 9
Among the dysregulated mRNAs, GSN, ORC1, SOX6, NKD2 and ADAMTS19 were involved in the ceRNA network (Figure 8); EPHA5 and TLN2 were involved in both the PPI and ceRNA networks (Figures 6, 8). Moreover, three lncRNAs (TMEM92-AS1, TNXA and CEROX1) were significantly downregulated, while one lncRNA (MIR4435-2HG) was significantly upregulated in the inflamed group compared with the control group (Figure 9B). The expression of the remaining four lncRNAs did not significantly differ between the groups according to PCR analysis.
Establishment of a competing endogenous RNA subnetwork based on RNAs verified by polymerase chain reaction analyses
We constructed a lncRNA-miRNA-mRNA subnetwork using the above validated PCR results for further investigation. The network included three miRNAs, seven mRNAs and four lncRNAs (Figure 10).
FIGURE 10
Correlation between DEGs and differential immune cells in synovial tissues following knee trauma
Forty-five immune/inflammatory-related hub genes from the PPI and ceRNA networks were selected mainly based on the degrees of the hub genes. CD8 T cells and M1 macrophages were significantly increased in inflamed synovial tissues. Correlations among the 45 DEGs and 16 kinds of immune cells were analysed between inflamed and normal synovial tissues in knee trauma, as shown in the correlation heatmap graph (Figure 11). Significantly related DEGs and immune cells were screened by |R| > 0.40 and p < 0.001. The results indicated that MMP9 correlated positively with M0 macrophages (R = 0.99, p = 0.00033) and plasma cells (R = 0.99, p = 0.00033), NKD2 correlated positively with CD8 T cells (R = 0.98, p = 0.00090), and CCR7 (R = 0.99, p = 0.00003) and IL2RB (R = 0.99, p = 0.00017) correlated positively with naive B cells.).
FIGURE 11
Discussion
ACL and meniscus tears are common knee injuries. Emerging evidence suggests that joint trauma is a major cause of OA. Moreover, approximately 50% of patients with knee trauma eventually develop PTOA several years after their injuries (; ). Nonetheless, the factors that contribute to PTOA development remain unclear. Recently, attention has turned to the importance of synovial inflammation, which may play a role in OA progression (). To better explore the etiology and evolution of PTOA, the specific molecular mechanisms of synovial inflammation following knee injuries need to be understood. Noncoding RNAs have important regulatory roles in the pathogenesis of OA (; ). By regulating the expression of specific gene targets, noncoding RNAs may play an essential role in establishing and maintaining the homeostatic balance of biological systems. Furthermore, studies have also suggested that biological changes in the joint after injury may contribute to PTOA development (; ). There are some previous studies on synovial inflammation, but the overall design of these studies involved RNA-seq for synovial tissues from inflammatory/degenerative joint diseases compared with healthy individuals/trauma patients (; ). To our knowledge, high-throughput RNA sequencing of inflamed and normal synovial tissues following ACL/meniscus injury have not been performed. Thus, in the present study, we conducted RNA-seq to systematically analyze the differentially expressed lncRNAs, miRNAs and mRNAs between inflamed and normal synovial membranes and established a ceRNA regulatory network to uncover the corresponding underlying pathogenesis of PTOA.
In the present study, 2793 mRNAs, 211 miRNAs and 3392 lncRNAs were significantly upregulated or downregulated between inflamed and normal synovial membranes of patients following knee trauma. To further investigate the potential biological roles of the aberrantly expressed mRNAs, GO and KEGG pathway analyses. The top significantly enriched upregulated GO terms were conducted in the BP category in terms of fold enrichment, such as immune response (GO: 0006955), immune system process (GO: 0002376), inflammatory response (GO: 0006954), cytokine-mediated signaling pathway (GO: 0019221), and chemotaxis (GO: 0006935), revealed the occurrence of a localized synovial membrane immune response and inflammatory process in a subset of knees with ACL/meniscus injury. Previous studies have revealed that subjects diagnosed with primary OA exhibit elevated percentages of activated macrophages and T cells in peripheral blood, synovial fluid, and synovial tissues (; ). Specifically, a recent study has revealed a T-cell-predominant immune profile in the synovial fluid following ACL and meniscus injuries (). The immune cells present after joint injuries may play a vital role in the development of PTOA. Further studies will be needed to investigate the relationships among macrophages, monocytes, and T cells to better understand the pathogenesis of PTOA following joint injury.
The pathway analyses revealed 41 upregulated and 1 downregulated enriched pathways, which helped to further elucidate the underlying functions of the differentially expressed mRNAs. The notable upregulated pathway terms included the systemic lupus erythematosus, hematopoietic cell lineage, Th17-cell differentiation, Th1- and Th2-cell differentiation, cytokine–cytokine receptor interaction, NF-kappa B signaling pathway, and RA signaling pathway terms. Several signaling pathways, such as the hematopoietic cell lineage pathway, the phagosome pathway, extracellular matrix receptor interaction, natural killer cell–mediated toxicity, and T cell receptor signaling pathways, which are similar to the results of a synovial fluid proteomic study (), might be associated with the inflammatory response after joint injury. Moreover, eight of the top 10 upregulated pathways in KEGG pathway analysis were related to immune diseases or the immune response. The upregulation of the RA pathway, which has also been reported in the knee synovium in the context of OA (), suggests that the initial synovial membrane response to ACL/meniscus injuries is similar to RA (). The cardinal sign of RA is damage to cartilage and bone owing to synovial invasion into adjacent articular structures (). Therefore, a RA-like synovial response after ACL/meniscus injuries may imply progressive cartilage degradation (). In addition, Th1-, Th2- and Th17-cell differentiation pathways were significantly upregulated in this study. Similarly, studies have revealed that high percentages of Th cells are present in blood samples and synovial fluid from RA and OA subjects (; ). Recently, also found that the numbers of immune cells, primarily T cells with multiple Th phenotypes, are elevated in the synovial fluid following ACL and meniscus injuries, while the numbers of Th1, Th2, and Th17 cells are the dominant populations of the CD4 subsets. Furthermore, T17 cells can produce IL-17, which causes synovial fibroblasts, chondrocytes, macrophages, and osteoclasts to elicit a cascade and finally promotes inflammation, cartilage degradation, and changes in bone metabolism (). Therefore, these enriched immune cells may play an important role in joint changes that account for the pathogenesis of PTOA following ACL and meniscus injuries.
Moreover, we conducted PPI network analysis to further characterize the differentially expressed mRNAs. EPHA5 and TLN2 were involved in the network; these findings were verified by PCR analyses. EphA5, a member of the Eph-Ephrin signaling axis, can play a dual role in the growth regulation of human bone marrow stromal cells, which might be involved in bone remodeling (; ). Another study has demonstrated that miR-34a can target EphA5, resulting in negative modulation of chondrogenesis (). In this study, EphA5 was downregulated in the inflamed synovium after knee injury, which might be related to the progression of PTOA.
Analyses of ceRNA networks, noncoding endogenous transcripts that compete for shared miRNAs, have exciting implications for diverse biological systems and pathophysiological conditions (). Because miRNAs are the cores of ceRNA networks, the DE miRNAs in RNA-seq analysis were firstly evaluated by a secondary PCR analysis approach. Our results revealed that four miRNAs were DE in inflamed synovium compared with normal synovium. Previous studies have shown that miR-486-5p is upregulated in patients with knee OA and that it might aggravate the progression of OA (; ). Inhibition of miR-486-5p significantly increases cell proliferation and decreases apoptosis in murine chondrogenic cells (). However, Chen et al. reported that exosomal miR-486-5p derived from RA fibroblast-like synoviocytes can promote osteoblast differentiation and alleviate the disease severity of RA (). In our study, miR-486-5p was upregulated after knee injury. Therefore, more in-depth studies are needed to investigate the biological role of miR-486-5p after knee trauma. Previous studies have also found that miR-199a-3p can directly regulate cyclooxygenase-2 expression and prostaglandin E2 production in IL-1β-stimulated human OA chondrocytes, suggesting that miR-199a-3p might be a novel target for OA therapy (; ). Similarly, in our data, the expression of miR-199a-3p was downregulated in inflamed synovium, possibly indicating a destructive effect in articular cartilage.
Next, ceRNA networks were constructed using bioinformatics methods based on the differentially expressed mRNAs, lncRNAs and verified miRNAs. Then, subsets of RNAs in the networks were analyzed by PCR to establish a subnetwork. Recently, some mRNAs have been confirmed to be associated with OA, chondrogenesis or osteogenesis. For example, studies have revealed that bone marrow stromal cells and adipose stem cells electroporation-mediated transfer of a trio of SOX genes (SOX-5, SOX-6, and SOX-9) can enhance chondrogenesis potential in vitro and regeneration of defective cartilage (; ). The levels of GSN, which was downregulated in our study, have also been shown to be decreased in patients with RA, suggesting local consumption of potentially anti-inflammatory proteins in the inflamed joint (). NKD2, a signal-inducible feedback antagonist of the canonical Wnt signaling pathway, can promote the differentiation of dental follicle stem/progenitor cells into osteoblasts ().
With respect to lncRNAs in the ceRNA subnetwork, it has recently been reported that MIR4435-2HG is downregulated in OA and can regulate chondrocyte proliferation and apoptosis (). Moreover, further study has demonstrated that MIR4435-2HG can significantly suppress the progression of OA via the miR-510-3p/IL-17A axis (). In the present study, MIR4435-2HG was upregulated in the inflamed synovium group after knee injury, which did not support our hypothesis that greater inflammation would lead to more cartilage breakdown. A recent study has also demonstrated that the concentrations of inflammatory markers in the synovial fluid are not associated with worse cartilage outcomes (), which may be attributable to time-dependent effects on the levels of inflammatory markers or individual variations in susceptibility of the cartilage to inflammation. TMEM92-AS1 has been shown to promote gastric cancer progression by targeting CCL5, and further study has shown that it may affect leukocytes via regulation of the expression of granulocyte colony-stimulating factor in gastric cancer tissues (). It is likely that deregulation of TNXA plays a key role in the development and/or progression of bladder cancer (). Cerox1 has been demonstrated to regulate mitochondrial oxidative phosphorylation to decrease reactive oxygen species production by binding to miR-488-3p (). Surprisingly, most of the above lncRNAs have not been extensively investigated in the context of OA. Thus, further studies are needed to assess their characteristics.
GO and KEGG enrichment analyses revealed that immune cells infiltrated the inflamed synovial tissues after ACL and meniscus injuries. Increasing evidence has shown that immune cell infiltration plays a key role in synovial inflammation and joint damage (Zhou et al., 2021; ). In this study, CD8 T cells and M1 macrophages were significantly increased in inflamed synovial tissues. Therefore, it is essential to further investigate the correlation among the important hub genes and immune cells following knee trauma. In this study, MMP9 correlated positively with M0 macrophages. M0 macrophages differentiate into M1 and M2 macrophages under specific circumstances, which may play a role in the immune imbalance related to RA pathogenesis. A study of esophageal cancer showed that MMP-9 might regulate tumour-associated macrophages (Yuan et al., 2021). Previous studies have shown that MMP-9 and macrophages participate in the pathogenesis of RA (Xu et al., 2021) and OA (). Our results indicate that MMP9 is significantly overexpressed. Therefore, we speculate that MMP9 may participate in the occurrence and development of PTOA through the MMP9-macrophage axis, which needs to be verified by further experiments. In the present study, NKD2 correlated positively with CD8 T cells. Recently, researchers observed a strong correlation between NKD2 expression and pro-inflammatory cytokine production in effector T cells, demonstrating that NKD2 might regulate the function of effector T cells, especially in an inflammatory status (). Intriguingly, the biological function of the NKD2-CD8 T-cell axis merits further investigation to understand the underlying mechanism and provide potential therapeutic targets for PTOA.
In summary, the present study conducted RNA-seq between inflamed and normal synovial tissues, and bioinformatics/PCR experiments were used to analyse the transcriptional expression characteristics of knee ACL/meniscus injuries. The most predominant features of synovitis after knee trauma were an increased immune response and immune cell infiltration. The essential molecules of the regulatory network identified in this study provide potential biomarkers for PTOA diagnosis, development and treatment. However, subsequent studies investigating the relationship between immune cells/essential molecules and joint degeneration are needed.
The small sample size is an obvious limitation of this study. Three patients with an inflamed synovium and 3 patients with a normal synovium do not fully reflect all the aspects of synovial profiling. Thus, it is necessary to expand the sample size to reduce these limitations. In addition, the functions of the above lncRNAs, miRNAs and mRNAs in ceRNA networks have not been explored in various cells related to PTOA. Further fundamental studies are needed to investigate the roles of these molecules in the pathogenesis and development of PTOA.
Conclusion
In conclusion, our study is the first to detect and analyze mRNA, lncRNA, and miRNA differences between inflamed and normal synovial membranes in injured ACL and/or meniscus. This study reveals novel ceRNA and PPI networks, which may be valuable for PTOA pathogenesis and diagnosis. These immune cells that are present following ACL and meniscus injuries may contribute to the development of PTOA. In addition, this study shows that immune-related DEGs have the potential to serve as biomarkers for PTOA treatment. Future studies that investigating the relationship between immune cells/essential molecules and joint degeneration may contribute to a profound understanding of the pathophysiology of PTOA after joint injury.
Statements
Data availability statement
The datasets presented in this study can be found in online repositories. The name of the repository and accession numbers can be found below: GEO, NCBI; GSE213070.
Ethics statement
The studies involving human participants were reviewed and approved by this study was performed in accordance with the principle of the Helsinki Declaration and approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (IORG No: IORG0003571). The patients/participants provided their written informed consent to participate in this study.
Author contributions
XX, XY, and ZY conceived the project. SR and CM performed the experiments and collected the data. XX conducted the bioinformatics analyses. XX and SR wrote the manuscript. XY, ZY, and CM revised the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by the Research Funds of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2018xhyn012).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2022.983020/full#supplementary-material
SUPPLEMENTARY TABLE S1The miRNA primers used in qRT-PCR.
SUPPLEMENTARY TABLE S2The mRNA primers used in qRT-PCR.
SUPPLEMENTARY TABLE S3The lnc RNA primers used in qRT-PCR.
SUPPLEMENTARY DATA S1Differentially expressed miRNAs between the inflamed group and the control group.
SUPPLEMENTARY DATA S2Differentially expressed mRNAs between the inflamed group and the control group.
SUPPLEMENTARY DATA S3Differentially expressed lncRNAs between the inflamed group and the control group.
SUPPLEMENTARY DATA S4Upregulated GO Biological Process analysis between the two groups.
SUPPLEMENTARY DATA S5Downregulated GO Biological Process Analysis between the two groups.
SUPPLEMENTARY DATA S6Upregulated KEGG Pathway Analysis between the two groups.
SUPPLEMENTARY DATA S7Downregulated KEGG Pathway Analysis between the two groups.
SUPPLEMENTARY DATA S8Overlapping genes with two immune databases.
SUPPLEMENTARY DATA S9The topological characteristics of nodes in the PPI networks.
SUPPLEMENTARY DATA S10The topological characteristics of nodes in the ceRNA networks.
Glossary
- OA
Osteoarthritis
- ACL
Anterior cruciate ligament
- PTOA
Posttraumatic osteoarthritis
- RNA-seq
RNA sequencing
- miRNAs
MicroRNAs
- lncRNAs
Long noncoding RNAs
- ceRNA
Competing endogenous RNA
- H&E
Hematoxylin-eosin
- RT–PCR
Real-time polymerase chain reaction
- DE
Differentially expressed
- GO
Gene Ontology
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- PPI
Protein–protein interaction
- BP
Biological process
- RA
Rheumatoid arthritis
- IL6
Interleukin 6
- IL2
Interleukin 2
- IL17
Interleukin 17
- IL-17A
Interleukin 17A
- IL-1
Interleukin 1
- CCR7
Cinnamoyl-CoA reductase 7
- CCR5
Cinnamoyl-CoA reductase 5
- CCR3
Cinnamoyl-CoA reductase 3
- CCR2
Cinnamoyl-CoA reductase 2
- CCR8
Cinnamoyl-CoA reductase 8
- C3
Complement C3
- CXCR3
C-X-C motif chemokine receptor 3
- CXCL8
C-X-C motif chemokine ligand 8
- CXCL1
C-X-C motif chemokine ligand 1
- CXCL10
C-X-C motif chemokine ligand 10
- CXCL2
C-X-C motif chemokine ligand 2
- CCL5
C-C motif chemokine ligand 5
- AGT
Angiotensinogen
- NOS1
Nitric oxide synthase 1
- GSN
Gelsolin
- ORC1
Origin recognition complex subunit 1
- SOX
Sex-determining region Y-box transcription factor
- SOX-5
Sex-determining region Y-box transcription factor 5
- SOX-6
Sex-determining region Y-box transcription factor 6
- SOX-9
Sex-determining region Y-box transcription factor 9
- NKD2
Naked cuticle homolog 2
- ADAMTS19
A disintegrin and metalloproteinase with thrombospondin type 1 motif 19
- EPHA5
Ephrin receptor A5
- TLN2
Talin 2
- TNXA
Tenascin-XA
- CEROX1
cytoplasmic endogenous regulator of oxidative phosphorylation 1
- Th1
Helper T1
- Th2
Helper T2
- Th17
Helper T17
- DEGs
Differentially expressed genes
- MMP9
Matrix metallopeptidase 9
- IL2RB
Interleukin 2 receptor subunit beta
- RA
Rheumatoid arthritis
References
1
AkhtarN.HaqqiT. M. (2012). MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann. Rheum. Dis.71 (6), 1073–1080. 10.1136/annrheumdis-2011-200519
2
AkpinarB.ThorhauerE.IrrgangJ. J.TashmanS.FuF. H.AnderstW. J. (2018). Alteration of knee kinematics after anatomic anterior cruciate ligament reconstruction is dependent on associated meniscal injury. Am. J. Sports Med.46 (5), 1158–1165. 10.1177/0363546517753386
3
AliS. A.PeffersM. J.OrmsethM. J.JurisicaI.KapoorM. (2021). The non-coding RNA interactome in joint health and disease. Nat. Rev. Rheumatol.17 (11), 692–705. 10.1038/s41584-021-00687-y
4
AlonsoB.BravoB.MediavillaL.GortazarA. R.ForriolF.VaqueroJ.et al (2020). Osteoarthritis-related biomarkers profile in chronic anterior cruciate ligament injured knee. Knee27 (1), 51–60. 10.1016/j.knee.2019.12.007
5
AmanoK.HuebnerJ. L.StablerT. V.TanakaM.McCullochC. E.LobachI.et al (2018). Synovial fluid profile at the time of anterior cruciate ligament reconstruction and its association with cartilage matrix composition 3 Years after surgery. Am. J. Sports Med.46 (4), 890–899. 10.1177/0363546517749834
6
ArthurA.GronthosS. (2021). Eph-ephrin signaling mediates cross-talk within the bone microenvironment. Front. Cell Dev. Biol.9, 598612. 10.3389/fcell.2021.598612
7
AyralX. (1996). Diagnostic and quantitative arthroscopy: Quantitative arthroscopy. Baillieres Clin. Rheumatol.10 (3), 477–494. 10.1016/s0950-3579(96)80045-8
8
AyralX.PickeringE. H.WoodworthT. G.MackillopN.DougadosM. (2005). Synovitis: A potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr. Cartil.13 (5), 361–367. 10.1016/j.joca.2005.01.005
9
ChangQ.JiM.LiC.GengR. (2020). Downregulation of miR4865p alleviates LPSinduced inflammatory injury, oxidative stress and apoptosis in Chondrogenic cell ATDC5 by targeting NRF1. Mol. Med. Rep.22 (3), 2123–2131. 10.3892/mmr.2020.11289
10
ChenC.ZhangJ.LingJ.DuY.HouY. (2018). Nkd2 promotes the differentiation of dental follicle stem/progenitor cells into osteoblasts. Int. J. Mol. Med.42 (5), 2403–2414. 10.3892/ijmm.2018.3822
11
ChenJ.LiuM.LuoX.PengL.ZhaoZ.HeC.et al (2020). Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1/BMP/Smad pathway. Biomater. Sci.8 (12), 3430–3442. 10.1039/c9bm01761e
12
ClairA. J.KingeryM. T.AnilU.KennyL.KirschT.StraussE. J. (2019). Alterations in synovial fluid biomarker levels in knees with meniscal injury as compared with asymptomatic contralateral knees. Am. J. Sports Med.47 (4), 847–856. 10.1177/0363546519825498
13
HagemansF. J. A.LarssonS.ReijmanM.FrobellR. B.StruglicsA.MeuffelsD. E. (2021). An anterior cruciate ligament rupture increases levels of urine N-terminal cross-linked telopeptide of type I collagen, urine C-terminal cross-linked telopeptide of type II collagen, serum aggrecan ARGS neoepitope, and serum tumor necrosis factor-α.Am. J. Sports Med.49 (13), 3534–3543. 10.1177/03635465211042310
14
HuX.NiS.ZhaoK.QianJ.DuanY. (2022). Bioinformatics-led discovery of osteoarthritis biomarkers and inflammatory infiltrates. Front. Immunol.13, 871008. 10.3389/fimmu.2022.871008
15
ImG. I.KimH. J. (2011). Electroporation-mediated gene transfer of SOX trio to enhance chondrogenesis in adipose stem cells. Osteoarthr. Cartil.19 (4), 449–457. 10.1016/j.joca.2011.01.005
16
JacobsC. A.HuntE. R.ConleyC. E.JohnsonD. L.StoneA. V.HuebnerJ. L.et al (2020). Dysregulated inflammatory response related to cartilage degradation after ACL injury. Med. Sci. Sports Exerc.52 (3), 535–541. 10.1249/MSS.0000000000002161
17
KimD.SongJ.KimS.ChunC. H.JinE. J. (2011). MicroRNA-34a regulates migration of chondroblast and IL-1β-induced degeneration of chondrocytes by targeting EphA5.Biochem. Biophys. Res. Commun.415 (4), 551–557. 10.1016/j.bbrc.2011.10.087
18
KimH. J.ImG. I. (2011). Electroporation-mediated transfer of SOX trio genes (SOX-5, SOX-6, and SOX-9) to enhance the chondrogenesis of mesenchymal stem cells. Stem Cells Dev.20 (12), 2103–2114. 10.1089/scd.2010.0516
19
Kim-WangS. Y.HoltA. G.McGowanA. M.DanylukS. T.GoodeA. P.LauB. C.et al (2021). Immune cell profiles in synovial fluid after anterior cruciate ligament and meniscus injuries. Arthritis Res. Ther.23 (1), 280. 10.1186/s13075-021-02661-1
20
KingJ. D.RowlandG.Villasante TezanosA. G.WarwickJ.KrausV. B.LattermannC.et al (2020). Joint fluid proteome after anterior cruciate ligament rupture reflects an acute posttraumatic inflammatory and chondrodegenerative state. Cartilage11 (3), 329–337. 10.1177/1947603518790009
21
KoendersM. I.JoostenL. A.van den BergW. B. (2006). Potential new targets in arthritis therapy: Interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann. Rheum. Dis.65 (3), iii29–33. 10.1136/ard.2006.058529
22
KongR.GaoJ.SiY.ZhaoD. (2017). Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis. Am. J. Transl. Res.9 (6), 2852–2864.
23
KotsifakiA.KorakakisV.WhiteleyR.Van RossomS.JonkersI. (2020). Measuring only hop distance during single leg hop testing is insufficient to detect deficits in knee function after ACL reconstruction: A systematic review and meta-analysis. Br. J. Sports Med.54 (3), 139–153. 10.1136/bjsports-2018-099918
24
KurokiK.WilliamsN.CookJ. L. (2021). Histologic evidence for a humoral immune response in synovitis associated with cranial cruciate ligament disease in dogs. Vet. Surg.50 (5), 1032–1041. 10.1111/vsu.13600
25
LambertC.DubucJ. E.MontellE.VergesJ.MunautC.NoelA.et al (2014). Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane. Arthritis Rheumatol.66 (4), 960–968. 10.1002/art.38315
26
LattermannC.JacobsC. A.Proffitt BunnellM.HustonL. J.GammonL. G.JohnsonD. L.et al (2017). A multicenter study of early anti-inflammatory treatment in patients with acute anterior cruciate ligament tear. Am. J. Sports Med.45 (2), 325–333. 10.1177/0363546516666818
27
LauwerysB. R.Hernandez-LobatoD.GrammeP.DucreuxJ.DessyA.FocantI.et al (2015). Heterogeneity of synovial molecular patterns in patients with arthritis. PLoS One10 (4), e0122104. 10.1371/journal.pone.0122104
28
LiY. S.LuoW.ZhuS. A.LeiG. H. (2017). T cells in osteoarthritis: Alterations and beyond. Front. Immunol.8, 356. 10.3389/fimmu.2017.00356
29
LiseeC.SpangJ. T.LoeserR.LongobardiL.LalushD.NissmanD.et al (2021). Tibiofemoral articular cartilage composition differs based on serum biochemical profiles following anterior cruciate ligament reconstruction. Osteoarthr. Cartil.29 (12), 1732–1740. 10.1016/j.joca.2021.09.005
30
LiuY.YangY.DingL.JiaY.JiY. (2020). LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging. Exp. Ther. Med.20 (2), 1693–1701. 10.3892/etm.2020.8841
31
LohmanderL. S.AtleyL. M.PietkaT. A.EyreD. R. (2003). The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum.48 (11), 3130–3139. 10.1002/art.11326
32
LohmanderL. S.EnglundP. M.DahlL. L.RoosE. M. (2007). The long-term consequence of anterior cruciate ligament and meniscus injuries: Osteoarthritis. Am. J. Sports Med.35 (10), 1756–1769. 10.1177/0363546507307396
33
LuratiA.LariaA.GattiA.BrandoB.ScarpelliniM. (2015). Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: Preliminary results of the MAGENTA CLICAO study. Open Access Rheumatol.7, 63–68. 10.2147/OARRR.S81905
34
OiestadB. E.EngebretsenL.StorheimK.RisbergM. A. (2009). Knee osteoarthritis after anterior cruciate ligament injury: A systematic review. Am. J. Sports Med.37 (7), 1434–1443. 10.1177/0363546509338827
35
OsbornT. M.VerdrenghM.StosselT. P.TarkowskiA.BokarewaM. (2008). Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res. Ther.10 (5), R117. 10.1186/ar2520
36
OstojicM.ZevrnjaA.VukojevicK.SoljicV. (2021). Immunofluorescence analysis of NF-KB and inos expression in different cell populations during early and advanced knee osteoarthritis. Int. J. Mol. Sci.22 (12), 6461. 10.3390/ijms22126461
37
RasheedZ.RasheedN.Al-ShobailiH. A. (2016). Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes. J. Cell. Mol. Med.20 (12), 2241–2248. 10.1111/jcmm.12897
38
ReynardL. N.BarterM. J. (2020). Osteoarthritis year in review 2019: Genetics, genomics and epigenetics. Osteoarthr. Cartil.28 (3), 275–284. 10.1016/j.joca.2019.11.010
39
RobinsonW. H.LepusC. M.WangQ.RaghuH.MaoR.LindstromT. M.et al (2016). Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol.12 (10), 580–592. 10.1038/nrrheum.2016.136
40
RosshirtN.HagmannS.TripelE.GotterbarmT.KirschJ.ZeifangF.et al (2019). A predominant Th1 polarization is present in synovial fluid of end-stage osteoarthritic knee joints: Analysis of peripheral blood, synovial fluid and synovial membrane. Clin. Exp. Immunol.195 (3), 395–406. 10.1111/cei.13230
41
Salazar-NorattoG. E.De NijsN.StevensH. Y.GibsonG.GuldbergR. E. (2019). Regional gene expression analysis of multiple tissues in an experimental animal model of post-traumatic osteoarthritis. Osteoarthr. Cartil.27 (2), 294–303. 10.1016/j.joca.2018.10.007
42
SellamJ.BerenbaumF. (2010). The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol.6 (11), 625–635. 10.1038/nrrheum.2010.159
43
ShiJ.GuoK.SuS.LiJ.LiC. (2018). miR4865p is upregulated in osteoarthritis and inhibits chondrocyte proliferation and migration by suppressing SMAD2. Mol. Med. Rep.18 (1), 502–508. 10.3892/mmr.2018.8931
44
SireyT. M.RobertsK.HaertyW.Bedoya-ReinaO.Rogatti-GranadosS.TanJ. Y.et al (2019). The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity. Elife8, e45051. 10.7554/eLife.45051
45
SmolenJ. S.AletahaD.BartonA.BurmesterG. R.EmeryP.FiresteinG. S.et al (2018). Rheumatoid arthritis. Nat. Rev. Dis. Prim.4, 18001. 10.1038/nrdp.2018.1
46
SongS.HeX.WangJ.SongH.WangY.LiuY.et al (2021). A novel long noncoding RNA, TMEM92-AS1, promotes gastric cancer progression by binding to YBX1 to mediate CCL5. Mol. Oncol.15 (4), 1256–1273. 10.1002/1878-0261.12863
47
StiebelM.MillerL. E.BlockJ. E. (2014). Post-traumatic knee osteoarthritis in the young patient: Therapeutic dilemmas and emerging technologies. Open Access J. Sports Med.5, 73–79. 10.2147/OAJSM.S61865
48
TavallaeeG.RockelJ. S.LivelyS.KapoorM. (2020). MicroRNAs in synovial pathology associated with osteoarthritis. Front. Med.7, 376. 10.3389/fmed.2020.00376
49
TayY.RinnJ.PandolfiP. P. (2014). The multilayered complexity of ceRNA crosstalk and competition. Nature505 (7483), 344–352. 10.1038/nature12986
50
ThomasE.PeatG.CroftP. (2014). Defining and mapping the person with osteoarthritis for population studies and public health. Rheumatol. Oxf.53 (2), 338–345. 10.1093/rheumatology/ket346
51
WangL.FengZ.WangX.WangX.ZhangX. (2010). DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics26 (1), 136–138. 10.1093/bioinformatics/btp612
52
WangM.LinZ.WangW.ChenL.XiaH.ZhangY.et al (2021). Kinematic alterations after anterior cruciate ligament reconstruction via transtibial techniques with medial meniscal repair versus partial medial meniscectomy. Am. J. Sports Med.49 (12), 3293–3301. 10.1177/03635465211033982
53
WangY.HouL.YuanX.XuN.ZhaoS.YangL.et al (2020). LncRNA NEAT1 targets fibroblast-like synoviocytes in rheumatoid arthritis via the miR-410-3p/YY1 Axis. Front. Immunol.11, 1975. 10.3389/fimmu.2020.01975
54
WoetzelD.HuberR.KupferP.PohlersD.PfaffM.DrieschD.et al (2014). Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation. Arthritis Res. Ther.16 (2), R84. 10.1186/ar4526
55
WuB.WooJ. S.SunZ.SrikanthS.GwackY. (2022). Ca(2+) signaling augmented by ORAI1 trafficking regulates the pathogenic state of effector T cells. J. Immunol.208 (6), 1329–1340. 10.4049/jimmunol.2100871
56
XiangS.LiZ.BianY.WengX. (2019). Identification of changed expression of mRNAs and lncRNAs in osteoarthritic synovium by RNA-sequencing. Gene685, 55–61. 10.1016/j.gene.2018.10.076
57
XiangS.LiZ.BianY.WengX. (2019). RNA sequencing reveals the circular RNA expression profiles of osteoarthritic synovium. J. Cell. Biochem.120 (10), 18031–18040. 10.1002/jcb.29106
58
XiaoY.BaoY.TangL.WangL. (2019). LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis. J. Orthop. Surg. Res.14 (1), 247. 10.1186/s13018-019-1278-7
59
XuJ.ZhangM. Y.JiaoW.HuC. Q.WuD. B.YuJ. H.et al (2021). Identification of candidate genes related to synovial macrophages in rheumatoid arthritis by bioinformatics analysis. Int. J. Gen. Med.14, 7687–7697. 10.2147/IJGM.S333512
60
YamadaT.YoshiiT.YasudaH.OkawaA.SotomeS. (2016). Dexamethasone regulates EphA5, a potential inhibitory factor with osteogenic capability of human bone marrow stromal cells. Stem Cells Int.2016, 1301608. 10.1155/2016/1301608
61
YuanX.LiuK.LiY.ZhangA. Z.WangX. L.JiangC. H.et al (2021). HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma. Clin. Transl. Oncol.23 (11), 2382–2393. 10.1007/s12094-021-02642-5
62
ZhouJ.ZhaoY.WuG.LinB.LiZ.LiuX. (2018). Differential miRNAomics of the synovial membrane in knee osteoarthritis induced by bilateral anterior cruciate ligament transection in rats. Mol. Med. Rep.18 (4), 4051–4057. 10.3892/mmr.2018.9385
63
ZhouS.LuH.XiongM. (2021). Identifying immune cell infiltration and effective diagnostic biomarkers in rheumatoid arthritis by bioinformatics analysis. Front. Immunol.12, 726747. 10.3389/fimmu.2021.726747
64
ZhouY.WangZ.ChenX.ZhangJ.YangL.LiuS.et al (2020). Identification of differentially expressed miRNAs and mRNAs in synovial of osteoarthritis via RNA-sequencing. BMC Med. Genet.21 (1), 46. 10.1186/s12881-020-0978-5
65
ZhuY. P.BianX. J.YeD. W.YaoX. D.ZhangS. L.DaiB.et al (2014). Long noncoding RNA expression signatures of bladder cancer revealed by microarray. Oncol. Lett.7 (4), 1197–1202. 10.3892/ol.2014.1843
Summary
Keywords
anterior cruciate ligament, meniscus, synovitis, RNA sequencing, competing endogenous RNA, immune infiltration
Citation
Xiao X, Yang X, Ren S, Meng C and Yang Z (2022) Construction and analysis of a lncRNA–miRNA–mRNA competing endogenous RNA network from inflamed and normal synovial tissues after anterior cruciate ligament and/or meniscus injuries. Front. Genet. 13:983020. doi: 10.3389/fgene.2022.983020
Received
30 June 2022
Accepted
15 September 2022
Published
17 October 2022
Volume
13 - 2022
Edited by
Fan He, Soochow University, China
Reviewed by
Simin Li, Southern Medical University, China
Huangan Wu, Shanghai University of Traditional Chinese Medicine, China
Updates
Copyright
© 2022 Xiao, Yang, Ren, Meng and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chunqing Meng, 317181950@qq.com; Zhaohui Yang, annyhao430@163.com
This article was submitted to RNA, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.